About the Conference

The aim of this international conference series is to provide an interactive platform for the exchange of new concepts, ideas and data between immunologists interested in ILCs and innate lymphocytes in health and disease. ILCs are recently described tissue-resident cells increasingly implicated across a spectrum of diseases, including in humans. New methods, some rapidly evolving, have enabled a deeper look at the role of these cells in tissue health. Unappreciated plasticity, migration and functions are being uncovered every day, necessitating a timely update of standard methods, technologies and functional assays required for purification, imaging and analysis of ILCs with unprecedented detail, including single-cell sequencing and multi-parameter protein-based approaches. Attendees will learn the state-of-the-art current understanding of these fascinating cells from world experts in all facets of their biology.

Planning Committee & Co-Chairs

Richard Locksley, MD, Chair

Marion and Herbert Sandler Distinguished Professorship in Asthma Research, Professor, Department of Medicine (Infectious Diseases), Howard Hughes Medical Institute

Ari Molofsky, MD, PhD, Co-Chair

Associate Professor, Laboratory Medicine, School of Medicine

Mark Ansel, PhD

Director, Biomedical Sciences Graduate Program, Department of Microbiology and Immunology

Lewis Lanier, PhD

Department of Microbiology and Immunology, Co-Leader, Cancer Immunology & Immunotherapy Program, Helen Diller Family Comprehensive Cancer Center

Susan Lynch, PhD

Director, Benioff Center for Microbiome Medicine, Associate Director, Microbiome in Inflammatory Bowel Disease program, Department of Medicine – Gastroenterology

Anna Molofsky, MD, PhD

UCSF Weill Institute for Neurosciences, San Francisco, USA

Tiffany Scharschmidt, MD

Associate Professor, Dermatology, School School of Medicine

Keynote Speakers - Joint Plenary Sessions

David Artis, PhD, Weill Cornell Medicine, New York, USA
Bana Jabri, MD, PhD, University of Chicago, Department of Medicine, Chicago, USA
Bana Jabri, MD, PhD, University of Chicago, Department of Medicine, Chicago, USA
Yasmine Belkaid, PhD, NIH National Institute of Allergy and Infectious Diseases, Bethesda, USA

Speakers - Joint Plenary Sessions

Marco Colonna, MD, Professor, Pathology & Immunology, Washington University St. Louis, USA
Marco Colonna, MD, Professor, Pathology & Immunology, Washington University St. Louis, USA
Anna Molofsky, MD, PhD, Assistant Professor, Department of Psychiatry, UCSF Weill Institute for Neurosciences, San Francisco, USA
Anna Molofsky, MD, PhD, Assistant Professor, Department of Psychiatry, UCSF Weill Institute for Neurosciences, San Francisco, USA
Ari Molofsky, MD, PhD, Associate Clinical Professor, Assistant Director of Clinical Labs Immunology Section, University of California, San Francisco, USA
Ari Molofsky, MD, PhD, Associate Clinical Professor, Assistant Director of Clinical Labs Immunology Section, University of California, San Francisco, USA
Kazuyo Moro, DDS, PhD, Department of Microbiology and Immunology, Graduate school of Medicine, Osaka University; RIKEN Center for Integrative Medical Sciences (IMS); Immunology Frontier Research Center (IFReC), Osaka University, Japan
Kazuyo Moro, DDS, PhD, Department of Microbiology and Immunology, Graduate school of Medicine, Osaka University; RIKEN Center for Integrative Medical Sciences (IMS); Immunology Frontier Research Center (IFReC), Osaka University, Japan
Henrique Veiga-Fernandes, PhD, Champalimaud Research Director and Senior Group Leader, Champalimaud Foundation, Lisbon, Portugal
Henrique Veiga-Fernandes, PhD, Champalimaud Research Director and Senior Group Leader, Champalimaud Foundation, Lisbon, Portugal

Speakers ILC4 Sessions

Gabrielle Belz, PhD, The University Queensland Diamantina Institute and The Walter and Eliza Hall Institute of Medical Research
Andreas Diefenbach, PhD, Director, Institute of Microbiology, Infectious Diseases and Immunology, Charité – Universitätsmedizin Berlin, Germany
Andreas Diefenbach, PhD, Director, Institute of Microbiology, Infectious Diseases and Immunology, Charité – Universitätsmedizin Berlin, Germany
James Di Santo, MD, PhD, Innate Immunity Unit, Department of Immunology, Institut Pasteur, Paris, France
Gérard Eberl, PhD, Department of Immunology, Microenvironment & Immunity Unit, Institut Pasteur, Paris, France
Gérard Eberl, PhD, Department of Immunology, Microenvironment & Immunity Unit, Institut Pasteur, Paris, France
Georg Gasteiger, MD, PhD, University of Würzburg, Germany
Georg Gasteiger, MD, PhD, University of Würzburg, Germany
Shigeo Koyasu, D.Sc., Executive Director, RIKEN Center for Integrative Medical Sciences (IMS), Japan
Shigeo Koyasu, D.Sc., Executive Director, RIKEN Center for Integrative Medical Sciences (IMS), Japan
Lewis Lanier, PhD, Professor, Microbiology and Immunology Chair, Microbiology and Immunology, University of California, San Francisco, USA
Lewis Lanier, PhD, Professor, Microbiology and Immunology Chair, Microbiology and Immunology, University of California, San Francisco, USA
Richard M. Locksley, MD, Sandler Distinguished Professor of Medicine and director of the Sandler Asthma Basic Research Center at University of California, San Francisco, USA
Richard M. Locksley, MD, Sandler Distinguished Professor of Medicine and director of the Sandler Asthma Basic Research Center at University of California, San Francisco, USA
Andrew McKenzie, PhD, University of Cambridge, Medical Research Council (MRC) Laboratory of Molecular Biology, Cambridge, UK
Jenny Mjösberg, PhD, Center for Infectious Medicine, ANA Futura Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
Fiona Powrie, FRS, Professor of Musculoskeletal Sciences and Director of the Kennedy Institute of Rheumatology, University of Oxford, UK
Chiara Romagnani, MD PhD, Innate Immunity, German Rheumatism Center (DRFZ) and Charitè Medical University Berlin, Germany
Chiara Romagnani, MD PhD, Innate Immunity, German Rheumatism Center (DRFZ) and Charitè Medical University Berlin, Germany
Gregory Sonnenberg, PhD, Associate Professor of Microbiology and Immunology in Medicine, Weill Cornell Medicine, USA
Gregory Sonnenberg, PhD, Associate Professor of Microbiology and Immunology in Medicine, Weill Cornell Medicine, USA
Hergen Spits, PhD, Amsterdam UMC, Amsterdam, Netherlands
Hergen Spits, PhD, Amsterdam UMC, Amsterdam, Netherlands
Éric Vivier, DVM, PhD, Aix-Marseille University and at the Public Hospital of Marseille, Marseille, France
Éric Vivier, DVM, PhD, Aix-Marseille University and at the Public Hospital of Marseille, Marseille, France
Elia Tait Wojno, PhD, Assistant Professor, Department of Immunology, University of Washington, USA
Elia Tait Wojno, PhD, Assistant Professor, Department of Immunology, University of Washington, USA

Click here to view all Speakers including Cytokines 2022 Sessions

ILC4 is organized under the auspices of the International Cytokine & Interferon Society

SPONSORING ORGANIZATIONS:

Latest News

News

On-Demand Access to Talks & Posters until 20 October

For On-Demand access click here: https://www.labroots.com/ms/virtual-event/cytokines2022hybrid then login with your email address that you used to register for the meeting. Do not click the button to register, use the Login button upper …

Confirmed Industry Sponsors as of today...

Platinum Sponsor

Gold Sponsor

Pfizer_Logo_Color_RGB

Silver Sponsors

Bronze Sponsors

Sponsors & Exhibitors


Current Time in Hawaii

23 March 2023, 22:46 PM

Download the Invitation

ILC4 2022 - 1st Announcement - v1